156 related articles for article (PubMed ID: 30827726)
21. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA
Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.
Polterauer S; Khalil S; Zivanovic O; Abu-Rustum NR; Hofstetter G; Concin N; Grimm C; Reinthaller A; Barakat RR; Leitao MM
Obstet Gynecol; 2012 Jun; 119(6):1210-8. PubMed ID: 22617586
[TBL] [Abstract][Full Text] [Related]
23. Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2.
Bishop EA; Java JJ; Moore KN; Walker JL
Int J Gynecol Cancer; 2017 May; 27(4):730-737. PubMed ID: 28399028
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of progression-free and overall survival between endometrial cancer patients treated with laparoscopic and open surgical techniques].
Póka R; Baradács I
Orv Hetil; 2020 Mar; 161(10):382-388. PubMed ID: 32115990
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population.
Kitao K; Yoshida S; Kennedy S; Takemura N; Sugimoto M; Deguchi M; Ohara N; Maruo T
Reprod Sci; 2007 May; 14(4):349-57. PubMed ID: 17644807
[TBL] [Abstract][Full Text] [Related]
27. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
28. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
29. Association Between Single Nucleotide Polymorphism +276G > T (rs1501299) in ADIPOQ and Endometrial Cancer.
Bieńkiewicz J; Smolarz B; Malinowski A
Pathol Oncol Res; 2016 Jan; 22(1):135-8. PubMed ID: 26386690
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of high-intermediate risk endometrial cancer according to European risk classification.
Rychlik A; Zapardiel I; Baquedano L; Martínez Maestre MÁ; Querleu D; Coronado Martín PJ
Int J Gynecol Cancer; 2020 Oct; 30(10):1528-1534. PubMed ID: 32817200
[TBL] [Abstract][Full Text] [Related]
31. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
[TBL] [Abstract][Full Text] [Related]
32. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
33. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
34. Impact of Metastatic Lymph Node to Total Lymph Node Ratio on Survival of Endometrial Cancer Patients.
Tangjitgamol S; Kittisiam T; Sriraumpuch J
Gynecol Obstet Invest; 2019; 84(5):463-471. PubMed ID: 30836353
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
36. Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.
Mahdi H; Munkarah AR; Ali-Fehmi R; Woessner J; Shah SN; Moslemi-Kebria M
Arch Gynecol Obstet; 2015 Jul; 292(1):183-90. PubMed ID: 25549769
[TBL] [Abstract][Full Text] [Related]
37. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
[TBL] [Abstract][Full Text] [Related]
38. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
Trovik J; Wik E; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; Njolstad TS; ; Vandenput I; Amant F; Akslen LA; Salvesen HB
Clin Cancer Res; 2011 May; 17(10):3368-77. PubMed ID: 21242118
[TBL] [Abstract][Full Text] [Related]
39. FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Jeske YW; Ali S; Byron SA; Gao F; Mannel RS; Ghebre RG; DiSilvestro PA; Lele SB; Pearl ML; Schmidt AP; Lankes HA; Ramirez NC; Rasty G; Powell M; Goodfellow PJ; Pollock PM
Gynecol Oncol; 2017 May; 145(2):366-373. PubMed ID: 28314589
[TBL] [Abstract][Full Text] [Related]
40. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
